checkAd

     155  0 Kommentare Endo Names Blaise Coleman President and Chief Executive Officer

    Mark Bradley Named Executive Vice President and Chief Financial Officer

    DUBLIN, Feb. 19, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that Blaise Coleman, who has served as the Company's Executive Vice President and Chief Financial Officer since 2016, will succeed Paul Campanelli as President and Chief Executive Officer and will become a member of the Board of Directors effective March 6, 2020. Mr. Campanelli will continue to serve as Chairman of the Board. This appointment will complete the Chief Executive Officer succession plan that Endo announced in November 2019.

    Blaise Coleman

    As a critical member of the executive leadership team, Mr. Coleman has successfully executed multiple, enterprise-wide strategic initiatives during Endo's multi-year transformation resulting in enhanced capabilities, operating simplification, and margin improvements. 

    "Blaise is uniquely qualified to lead Endo's continued transformation. In addition to his comprehensive financial background, Blaise has a successful track record of building high-performing teams and delivering strong results," said Paul Campanelli, Endo's Chairman, President and Chief Executive Officer. "His proven business leadership, extensive pharmaceutical expertise and deep understanding of the issues facing the industry make him the ideal leader to leverage the Company's strong operating performance to drive future growth." 

    "I am honored to build on Paul's legacy and excited to lead Endo in its next phase. I believe Endo has significant opportunities to create shareholder value and become the Company we aspire to be over the long term," said Mr. Coleman. "I would like to thank Paul and the Board for the opportunity to serve Endo's team members, patients and shareholders."

    Mr. Coleman has more than 20 years of pharmaceutical industry experience. Prior to joining Endo in 2015, he held a number of leadership roles of increasing responsibility with AstraZeneca and Johnson & Johnson.  He began his career at PricewaterhouseCoopers, LLP upon graduation from Widener University with a Bachelor of Science degree in accounting.  He also holds a Master of Business Administration from the Fuqua School of Business at Duke University.

    Seite 1 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Endo Names Blaise Coleman President and Chief Executive Officer Mark Bradley Named Executive Vice President and Chief Financial Officer DUBLIN, Feb. 19, 2020 /PRNewswire/ - Endo International plc (NASDAQ: ENDP) today announced that Blaise Coleman, who has served as the Company's Executive Vice President and …